BACK TO TOP
KSE100
152,740.37
-1551.88
(-1.01%)
KSE100PR
47,123.54
-622.52
(-1.30%)
ALLSHR
91,858.47
-800.10
(-0.86%)
KSE30
46,223.61
-681.25
(-1.45%)
KMI30
219,130.92
-2553.50
(-1.15%)
BKTI
42,104.45
-866.56
(-2.02%)
OGTI
32,077.86
-414.19
(-1.27%)
KMIALLSHR
59,625.28
-562.17
(-0.93%)
PSXDIV20
69,927.99
-687.04
(-0.97%)
UPP9
53,682.35
-510.06
(-0.94%)
NITPGI
40,489.29
-390.08
(-0.95%)
NBPPGI
44,154.38
-478.43
(-1.07%)
MZNPI
27,170.03
-307.33
(-1.12%)
JSMFI
39,349.43
-449.57
(-1.13%)
ACI
19,589.65
-274.31
(-1.38%)
JSGBKTI
62,840.90
-500.15
(-0.79%)
HBLTTI
18,102.91
18-03-2026
5.41
(0.03%)
MII30
19,880.46
-209.40
(-1.04%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.316.79
-4.70
(-1.46%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Mar 19, 2026 1:44 PM
REG
DFC
CSF
ODL
Open
319.00
High
324.00
Low
309.00
Volume
290,950
CIRCUIT BREAKER
289.34 — 353.64
DAY RANGE
309.00 — 324.00
52-WEEK RANGE ^
293.09 — 481.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
321.49
VAR
14.50
HAIRCUT
17.50
P/E Ratio (TTM) **
10.98
1-Year Change * ^
-23.12%
YTD Change * ^
-18.73%
Last update: Thu, Mar 19, 2026 1:33 PM
Open
318.00
High
318.00
Low
315.01
Close
317.00
Change
-1.55%
LDCP
322.00
Volume
1,500
Total Trades
2
CIRCUIT BREAKER
289.80 — 354.20
DAY RANGE
315.01 — 318.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Mon, Mar 2, 2026 1:35 PM
Open
0.00
High
0.00
Low
0.00
Close
351.00
Change
0.00%
LDCP
326.30
Volume
0
Total Trades
1
CIRCUIT BREAKER
293.67 — 358.93
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Dec 28, 2025 3:06 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
322.66
Volume
0
Total Trades
0
CIRCUIT BREAKER
290.39 — 354.93
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Erum Shakir RahimCEO
Lai Kuen GohChairperson
Hina MirCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
100,887,249.00
Shares
318,467,278
Free Float
63,693,456
Free Float
20.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 29, 2025Transmission of Quarterly Report for the period ended September 30, 2025 View   PDF
Oct 24, 2025Financial Results for the Quarter ended September 30, 2025 View   PDF
Aug 29, 2025Transmission of Half Yearly Report for the Period ended June 30, 2025 View   PDF
Aug 26, 2025Financial Results for the Quarter ended June 30, 2025 View   PDF
Apr 29, 2025Transmission of Quarterly Report for the period ended March 31, 2025 View   PDF
DateTitleDocument
Mar 18, 2026Board Meeting Quarter 4, 2025 View   PDF
Oct 16, 2025Notice of Board of Directors Meeting (Q3-2025) View   PDF
Aug 19, 2025Notice of Board of Directors Meeting (Q2- 2025) View   PDF
Apr 28, 2025Certified True Copy of the Resolutions passed by shareholders in the Annual General Meeting held on April 28, 2025 View   PDF
Apr 17, 2025Board Meeting Quarter ended March 31, 2025 View   PDF
DateTitleDocument
Dec 5, 2025Presentation for Corporate Briefing Session -2025 View   PDF
Dec 3, 2025Notice of Corporate Briefing Session - 2025 View   PDF
Sep 19, 2025Credit of Interim cash dividend View   PDF
Sep 2, 2025Notice of interim cash dividend and share book closure View   PDF
Sep 1, 2025Prior Publication of Notice of Interim Cash Dividend and Share Book Closure View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales61,187,50149,661,27741,841,58536,660,772
Profit after Taxation6,536,047533,9532,462,8925,354,409
EPS20.521.687.7316.81
Q3 2025Q2 2025Q1 2025Q3 2024
Sales14,188,00814,720,66715,580,14014,730,940
Profit after Taxation2,037,2852,068,8112,126,5471,927,134
EPS6.406.506.686.05
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)25.157.0517.4026.56
Net Profit Margin (%)10.681.085.8914.61
EPS Growth (%)1,121.43(78.27)(54.02)58.58
PEG0.02(0.63)(0.21)0.14

Payouts

Financial Reports